Hidradenitis suppurativa and Type 2 Diabetes: A Case Report
1★, 2, 2, 1, 1, 1★ Corresponding author
- 1Department of Pharmacy Practice, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, INDIA.
- 2Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, INDIA.
CORRESPONDENCE
Andhuvan Gandhi
Department of Pharmacy Practice, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, INDIA.
Received: 22-09-2021; Revised: 04-10-2021; Accepted: 23-10-2021.
Volume 13, Issue 4 · pp. 434-435 · 2021 · DOI: 10.5530/jyp.2021.13.103
ABSTRACT
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by lesions and abscesses associated with the apocrine gland. Suggested pathogenesis for the disease development include genetic mutations, impaired immuneregulation, and lifestyle factors.Strong associations with obesity and significant improvement in HS severity with weight loss have been reported in various literatures. A sequence of inflammatory events begins with the disruption of follicular epithelium leading to a huge immune response. Patients also become vulnerable to secondary bacterial infections. Diabetes due to its close relation with obesity, and anemia are commonly observed co-morbidities accompanying HS. Available treatment options include antibiotics, pain-relievers and biological therapy. This case report focusses on a 28 year old male admitted with typical symptoms of HS. The physical presentation and thorough blood work led to the diagnosisof HS and Type 2 diabetes mellitus (T2DM). Wound care and treatment with antibiotic combination, adalimumab and metformin showed to be effective.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gandhi, A., Gunasekaran, N., Ganesamoorthy, K., Tomson, M. M., Raju, R. R., & Abdulkhader, S. (2021). Hidradenitis suppurativa and Type 2 Diabetes: A Case Report. Journal of Young Pharmacists, 13(4), 434-435. https://doi.org/10.5530/jyp.2021.13.103
Copyright and licence
© 2021 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
